Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $49.8900 (0.85%) ($49.6500 - $49.8900) on Fri. Feb. 12, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.41% (three month average) | RSI | 55 | Latest Price | $49.8900(0.85%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.4% a day on average for past five trading days. | Weekly Trend | HALO advances 2.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(51%) IWO(51%) IWM(49%) IWC(46%) IWN(44%) | Factors Impacting HALO price | HALO will decline at least -1.205% in a week (0% probabilities). VIXM(-31%) UUP(-13%) VXX(-12%) IGOV(-3%) TBT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.205% (StdDev 2.41%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $50.04(-0.3%) | 10 Day Moving Average | $49.23(1.34%) | 20 Day Moving Average | $48.68(2.49%) | To recent high | -1.1% | To recent low | 29.4% | Market Cap | $6.819b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |